N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate

Repeated dose toxicity: oral

Administrative data

Endpoint:

sub-chronic toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1996

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

other:

Limit test:

no

Test material

Test material information

Constituent 1

Test animals

Species:

other:

Administration / exposure

Route of administration:

oral: unspecified

Results and discussion

Effect levels

1

Dose descriptor:

NOAEL

Effect level:

50 mg/kg bw/day (nominal)

Basis for effect level:

other:

2

Dose descriptor:

NOEL

Effect level:

< 50 mg/kg bw/day (nominal)

Basis for effect level:

other:

Target system / organ toxicity

Critical effects observed:

not specified